返回
A
Ahmet Emre Eşkazan
Cerrahpasa Faculty of Medicine
22H指数
265论文数
1.7K被引数
收录论文 57
发表时间
Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review关于在既往使用两种或多种酪氨酸激酶抑制剂后,在慢性期慢性髓性白血病中使用阿西米尼布的实世界数据:土耳其管理准入计划结果及文献综述
Leukemia Research
IF2.2
Lowering the platelet count threshold to 40x109/L for lumbar puncture: can this represent a generalized approach? Comment on: 40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies将血小板计数阈值降至40×10^9/L用于腰椎穿刺:这能否代表一种普遍适用的方法?——评论:“40是新的50”:减少血液系统恶性肿瘤成人患者腰椎穿刺前血小板输注的需求。
HAEMATOLOGICA
IF7.9

